放射性药物治疗市场基于(关键地区、市场参与者、规模和份额)- 到 2031 年的预测

  • Report Code : TIPRE00024328
  • Category : Pharmaceuticals
  • Status : Published
  • No. of Pages : 185
Buy Now

[研究报告]放射性药物治疗市场规模预计将从2022年的181458万美元增长到2028年的344197万美元;预计 2022 年至 2028 年间复合年增长率为 11.3%。

放射性药物治疗诊断市场根据产品类型、放射性同位素、来源、应用、适应症、最终用户和地理位置进行细分。该报告提供了市场的深入信息和分析,强调了放射性药物治疗诊断市场中普遍存在的动态、趋势和机会等参数。它还提供了全球放射性药物治疗诊断市场主要参与者的竞争格局分析。

市场前景

心血管疾病治疗中应用的不断增加推动了全球放射性药物治疗市场的增长放射性药物治疗诊断学

心血管疾病(CVD)是21世纪最流行的慢性疾病之一,死亡率很高。由于久坐的生活方式,CVD 是发达国家死亡和发病的主要原因。此外,肥胖、糖尿病和相关疾病与心血管疾病相关,并且正在成为共病。此外,冠状动脉阻塞等并发症是成人死亡的主要原因之一,导致动脉壁内膜(主要是颈动脉)形成血栓斑块。根据国家生物技术中心的数据,2015年全球约有1770万人因心血管疾病死亡。从这个意义上说,预计到2030年,心血管疾病的死亡率将增至2200万。心血管疾病的治疗应用包括纳米药物在心绞痛、心肌炎、心肌梗死、心包疾病、血栓、动脉粥样硬化、高脂血症、高血压、肺动脉等方面的应用。高血压和中风。治疗诊断纳米药物可以延长体循环,逃避宿主防御系统,并将治疗诊断药物递送到目标部位,以在细胞和分子水平上进行成像和治疗。

战略见解

根据美国疾病控制与预防中心 (CDC) 2022 年报告称,心脏病是美国男性和女性死亡的主要原因之一。2017 年,心脏病导致美国约 697,000 人死亡,占死亡人数的五分之一。 2020 年。美国国立卫生研究院 (NIH) 的一份报告指出,治疗诊断纳米颗粒在医学领域获得了极大关注,因为该技术有助于克服与 CVD 相关的复杂性和病理生理并发症。动脉粥样硬化患者的心血管成像提供了可能有助于治疗 CVD 的病理生理学证据。此外,治疗诊断纳米粒子可以与各种成像技术相结合,例如磁共振成像(MRI)、正电子发射断层扫描(PET)和计算机断层扫描(CT)。到目前为止,已经在临床实验室进行了多项临床研究。构建了一种三合一治疗复合物,将聚合物光声探针与纳米颗粒 PLCDP@PMH 相结合。体内临床评估表明,PLCDP@PMH 为检测患者早期动脉粥样硬化的治疗诊断方法提供了有利可图的优势。

基于产品类型的信息

基于产品类型,放射性药物治疗诊断市场分为正电子发射断层扫描(PET)示踪剂、β发射器和α发射器。到 2022 年,正电子发射断层扫描 (PET) 示踪剂细分市场在全球放射性药物治疗诊断市场中占据最大的市场份额,预计在预测期内复合年增长率最高。

按产品类型划分的放射性药物治疗诊断市场:2022-2028

基于放射性同位素的信息

基于放射性同位素,放射性药物治疗市场分为镥(Lu)177、镓-68、碘-131、碘-123 、锝-99、钇-90 (Y-90)、铜 (Cu) 64、18F、铜 (Cu) 67 等。到 2022 年,镥 (Lu) 177 细分市场在全球放射性药物治疗市场中占有最大的市场份额,预计在预测期内复合年增长率最高。

基于来源的信息

Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What is radiopharmaceutical theranostics?

Radiopharmaceuticals are radioisotopes that are bound to biological molecules that target specific tissues, organs, or cells within the human body. Radioisotopes emitting gamma rays are useful for diagnostic imaging where the radiation escapes the body. Nuclear medicine imaging generally utilizes radioactive isotopes attached to specific molecules to examine biological processes, such as disease pathophysiology. Every radiopharmaceutical is designed to travel to a specific location in the body, and as soon as it reaches the site, it releases radioactive substances that kill the tumor cells. Radiopharmaceuticals can target various malignancies such as prostate cancer, heart disease, thyroid cancer, and others. These drugs can also be used as both therapies and diagnostics, known as 'theranostics’. In theranostics, radiopharmaceuticals are used for therapeutic and diagnostic purposes by targeting one specific tumor receptor.

What are the driving factors for the radiopharmaceutical theranostics market across the globe?

Key factors that are driving the growth of this market are rising incidence of cancer and the growing application in the treatment of cardiovascular disorders are expected to boost the market growth for the radiopharmaceutical theranostics over the years.

What is the market CAGR value of radiopharmaceutical theranostics market during forecast period?

The CAGR value of the biopharmaceuticals market during the forecasted period of 2022-2028 is 11.3%.

Which product type leads the radiopharmaceutical theranostics market?

The positron emission tomography (PET) tracers segment held the largest share of the market in the global radiopharmaceutical theranostics market and held the largest market share of 44.76% in 2022.

Which radioisotope held the largest share in the radiopharmaceutical theranostics market?

The Lutetium (Lu) 177 segment dominated the global radiopharmaceutical theranostics market and held the largest market share of 24.34% in 2022.

Which source held the largest share in the radiopharmaceutical theranostics market?

The cyclotrons segment dominated the global radiopharmaceutical theranostics market and held the largest market share of 60.42% in 2022.

Which application held the largest share in the radiopharmaceutical theranostics market?

Answer: - The targeted therapeutic [Rx] segment dominated the global radiopharmaceutical theranostics market and held the largest market share of 63.28% in 2022.

Which indication held the largest share in the radiopharmaceutical theranostics market?

The oncology segment dominated the global radiopharmaceutical theranostics market and held the largest market share of 62.18% in 2022.

Which end user held the largest share in the radiopharmaceutical theranostics market?

The hospitals segment dominated the global radiopharmaceutical theranostics market and held the largest market share of 36.28% in 2022.

Who are the key players in the radiopharmaceutical theranostics market?

The radiopharmaceutical theranostics market majorly consists of the players such Bayer AG, GE HealthCare Technologies Inc, Curium, Lantheus Medical Imaging, Inc.; Telix Pharmaceuticals Ltd.; Cardinal Health Inc, Advanced Accelerator Applications S.A.; Jubilant Radiopharma, Theragnostics, and NuView Life Sciences amongst others.

The List of Companies - Radiopharmaceutical Theranostics Market

  1. Bayer AG
  2. GE HealthCare Technologies Inc
  3. Curium
  4. Lantheus Medical Imaging, Inc.     
  5. Telix Pharmaceuticals Ltd.
  6. Cardinal Health Inc
  7. Advanced Accelerator Applications S.A.
  8. Jubilant Radiopharma
  9. Theragnostics
  10. NuView Life Sciences

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports